EpiPen Familiarity May Prove Tough Hurdle For Generics

With EpiPen injector patent-protected and patients accustomed to its use, finding a substitutable generic device may prove difficult.

EpiPen

Sponsors and FDA may have a tough time developing and approving a non-Mylan NV sanctioned generic EpiPen (epinephrine), in part because any new product might have to overcome patients' familiarity with the brand competitor.

A different device already has been shown to potentially cause confusion, which is a concern because a generic could be...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Product Reviews

More from Pink Sheet